Simultaneous transapical paraprosthetic leak occlusion and valve-in-valve implantation into a degenerated mitral bioprosthesis.
Transcatheter valve-in-valve implantation is an emerging treatment option for high-risk patients with failing mitral bioprostheses. The presence of a paravalvular leak is considered a contraindication to this procedure that would leave the patient with significant residual regurgitation. The case is described of a patient with a severely degenerated 29 mm Carpentier-Edwards mitral bioprosthesis successfully treated by simultaneous transapical transcatheter valve-in-valve implantation and paraprosthetic leak occlusion. The potential advantages of this approach are discussed.
Alfredo Giuseppe
AG
Cerillo
Massimiliano
M
Mariani
Mattia
M
Glauber
Sergio
S
Berti
D000369:Aged, 80 and over; D001705:Bioprosthesis / Q000009:adverse effects*; D006328:Cardiac Catheterization; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D021621:Imaging, Three-Dimensional; D008297:Male; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000601:surgery*; D011475:Prosthesis Failure; D012086:Reoperation / Q000379:methods; D018084:Ultrasonography, Interventional